EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSMZEG00005006805
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSMZEG00005015845
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSMZEG00005005356
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSMZEG00005021117
Gene Symbol: HDAC4
4 Cross references
196 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSMZEG00005016741
Gene Symbol: HDAC4
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSMZEG00005018688
Gene Symbol: HDAC5
3 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSMZEG00005026767
Gene Symbol: HDAC6
3 Cross references
180 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSMZEG00005021888
Gene Symbol: HDAC7
3 Cross references
189 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSMZEG00005026979
Gene Symbol: LOC101467054
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSMZEG00005019954
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Histone-Lysine N-Methyltransferase Ezh2

Ensembl ID : ENSMZEG00005013706
Gene Symbol: LOC101464777
3 Cross references
225 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 1

Ensembl ID : ENSMZEG00005001166
Gene Symbol: HCAR1
4 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).